Evidence map›Paper›PMID 19008330›Full record

ArticleThe Journal of endocrinology2009

Corticotropin-releasing hormone receptor expression and functional signaling in murine gonadotrope-like cells.

Audrey F Seasholtz, Miina Ohman, Amale Wardani, Robert C Thompson

Open access · greenAbstract read
In one paragraph

Article in The Journal of endocrinology, 2009. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 3 papers.

0numbers the graph read from it
0cells of the map it votes in
3citing papers in PubMed
0.2field-weighted citation impact, top 54% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

3 citing papers in PubMed, 6 citations in OpenAlex.

  1. Article
  2. Article
  3. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

4 authors at 2 institutions in 2 countries.

Audrey F SeasholtzMolecular and Behavioral Neuroscience Institute, University of Michigan, 109 Zina Pitcher Place, Ann Arbor, Michigan 48109, USA. aseashol@umich.edu
Miina Ohman
Amale Wardani
Robert C Thompson
University of Michigan–Ann Arbor · USNeuroscience Institute · IT

Funding

CORTICOTROPIN RELEASING HORMONE BINDING PROTEINR01DK042730 · NIDDK · UNIVERSITY OF MICHIGAN AT ANN ARBOR · PI SEASHOLTZ, AUDREY F. · 1996 to 2004
$1.1M
ROLE OF UROCORTIN IN MAMMALIAN BRAIN AND PITUITARYR01DK057660 · NIDDK · UNIVERSITY OF MICHIGAN AT ANN ARBOR · PI SEASHOLTZ, AUDREY F. · 2001 to 2004
$975k
NUTRITIONAL CONTROL OF REPRODUCTIVE AND STRESS AXESR01DK054323 · NIDDK · UNIVERSITY OF MICHIGAN AT ANN ARBOR · PI THOMPSON, ROBERT C · 1999 to 2001
$292k
TRANSCRIPTIONAL REGULATION OF CRH GENE EXPRESSIONR29DK042730 · NIDDK · UNIVERSITY OF MICHIGAN AT ANN ARBOR · PI SEASHOLTZ, AUDREY F. · 1991 to 1995
–
NIDDK NIH HHS DK42730NIDDK NIH HHS DK54323NIDDK NIH HHS DK57660NIDDK NIH HHS R01 DK042730NIDDK NIH HHS R01 DK057660
6 · The paper itself

Abstract

Corticotropin-releasing hormone (CRH) is a key regulator of the mammalian stress response, mediating a wide variety of stress-associated behaviors including stress-induced inhibition of reproductive function. To investigate the potential direct action of CRH on pituitary gonadotrope function, we examined CRH receptor expression and second messenger signaling in alpha T3-1 cells, a murine gonadotrope-like cell line. Reverse transcriptase PCR (RT-PCR) studies demonstrated that alpha T3-1 cells express mRNA for the two CRH receptor subtypes, CRHR1 and CRHR2, with CRHR2alpha as the predominant CRHR2 isoform. Stimulation of the cells with CRH or urocortin (UCN) resulted in rapid, transient increases in the intracellular levels of cAMP that were completely blocked by the addition of alpha-helical CRH 9-41 or astressin, non-selective CRH receptor antagonists. Stimulation of the cells with CRHR2-specific ligands, urocortin 2 (UCN2) or urocortin 3 (UCN3), resulted in rapid increases in intracellular cAMP levels to 50-60% of the levels observed with UCN. Treatment with a selective CRHR2 antagonist, antisauvagine, completely blocked UCN3-mediated increases in cAMP and significantly reduced, but did not completely block UCN-mediated increases in cAMP, demonstrating that both CRHR1 and CRHR2 are functionally active in these gonadotrope-like cells. Finally, UCN treatment significantly increased the transcriptional activity of the glycoprotein hormone alpha-subunit promoter as assessed by alpha-luciferase transfection assays. Together, these results demonstrate the functional signaling of CRH receptors in alpha T3-1 cells, suggesting that CRH may also modulate pituitary gonadotrope function in vivo.

Indexed as

Signal TransductionAnimalsCell LineCorticotropin-Releasing HormoneCyclic AMPGene ExpressionGene Expression RegulationGonadotrophsIntracellular Signaling Peptides and ProteinsMiceProtein IsoformsReceptors, Corticotropin-Releasing HormoneReverse Transcriptase Polymerase Chain ReactionCorticotropin-Releasing HormoneCyclic AMPIntracellular Signaling Peptides and ProteinsProtein IsoformsReceptors, Corticotropin-Releasing Hormone

Identifiers

PMID19008330
PMCPMC2635417
OpenAlexW2132782816

What OpenQuestion holds

Textmetadata
LicenceTDM
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.